Bassil I. Dahiyat
CIK: 0001591312
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (17 total)
- Jun 30, 2026KOD
Kodiak Sciences Inc.
Award(A)DirectStock Option (Right to Buy)
17.7K shares- - Mar 6, 2026XNCR
Xencor Inc
Sale(S)Direct6.6K shares at avg. $11.02$73K - Mar 5, 2026XNCR
Xencor Inc
Sale(S)Direct14.9K shares at avg. $11.25$167K - Mar 3, 2026XNCR
Xencor Inc
Sale(S)Direct6.8K shares at avg. $11.90$80K - Mar 2, 2026XNCR
Xencor Inc
Award(A)Direct97.3K shares- - Dec 22, 2025XNCR
Xencor Inc
Exercise(M)Direct10.6K shares at avg. $12.51$133K - Dec 19, 2025XNCR
Xencor Inc
Sale(S)Direct114.4K shares at avg. $15.71$1.8M - Dec 19, 2025XNCR
Xencor Inc
Exercise(M)Direct114.4K shares at avg. $12.51$1.4M - Jun 30, 2025KOD
Kodiak Sciences Inc.
Award(A)DirectStock Option (Right to Buy)
40K shares- - Mar 10, 2025XNCR
Xencor Inc
Sale(S)Direct19.7K shares at avg. $13.60$268K - Mar 4, 2025XNCR
Xencor Inc
Award(A)Direct109.7K shares- - Feb 3, 2025XNCR
Xencor Inc
Exercise(M)Direct8.8K shares at avg. $15.69$138K - Nov 22, 2024XNCR
Xencor Inc
Exercise(M)Direct13.5K shares at avg. $15.69$213K - Nov 21, 2024XNCR
Xencor Inc
Sale(S)Direct49.3K shares at avg. $24.07$1.2M - Nov 21, 2024XNCR
Xencor Inc
Exercise(M)Direct49.3K shares at avg. $15.69$773K - Nov 13, 2024XNCR
Xencor Inc
Exercise(M)Direct3.4K shares at avg. $15.69$53K - Nov 13, 2024XNCR
Xencor Inc
Sale(S)Direct3.4K shares at avg. $24.02$81K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 30, 2026 |  KOD Kodiak Sciences Inc. | Award(A) Stock Option (Right to Buy) | 17,731 | - | - | Direct |
| Mar 6, 2026 |  XNCR Xencor Inc | Sale(S) | 6,606 | $11.02 | $72,796 | Direct |
| Mar 5, 2026 | XNCR Xencor Inc | Sale(S) | 14,870 | $11.25 | $167,221 | Direct |
| Mar 3, 2026 | XNCR Xencor Inc | Sale(S) | 6,758 | $11.90 | $80,387 | Direct |
| Mar 2, 2026 | XNCR Xencor Inc | Award(A) | 97,291 | - | $0 | Direct |
| Dec 22, 2025 | XNCR Xencor Inc | Exercise(M) | 10,624 | $12.51 | $132,906 | Direct |
| Dec 19, 2025 | XNCR Xencor Inc | Sale(S) | 114,377 | $15.71 | $1,796,863 | Direct |
| Dec 19, 2025 | XNCR Xencor Inc | Exercise(M) | 114,377 | $12.51 | $1,430,856 | Direct |
| Jun 30, 2025 | KOD Kodiak Sciences Inc. | Award(A) Stock Option (Right to Buy) | 40,000 | - | - | Direct |
| Mar 10, 2025 | XNCR Xencor Inc | Sale(S) | 19,716 | $13.60 | $268,080 | Direct |
| Mar 4, 2025 | XNCR Xencor Inc | Award(A) | 109,745 | - | - | Direct |
| Feb 3, 2025 | XNCR Xencor Inc | Exercise(M) | 8,808 | $15.69 | $138,198 | Direct |
| Nov 22, 2024 | XNCR Xencor Inc | Exercise(M) | 13,548 | $15.69 | $212,568 | Direct |
| Nov 21, 2024 | XNCR Xencor Inc | Sale(S) | 49,278 | $24.07 | $1,186,363 | Direct |
| Nov 21, 2024 | XNCR Xencor Inc | Exercise(M) | 49,278 | $15.69 | $773,172 | Direct |
| Nov 13, 2024 | XNCR Xencor Inc | Exercise(M) | 3,366 | $15.69 | $52,813 | Direct |
| Nov 13, 2024 | XNCR Xencor Inc | Sale(S) | 3,366 | $24.02 | $80,842 | Direct |
1-17 of 17 transactions
About Dahiyat Bassil I
Dahiyat Bassil I (SEC CIK 0001591312) files insider reports with the SEC as Director of Kodiak Sciences Inc. (KOD) and PRESIDENT & CEO of Xencor Inc (XNCR).
Signal8 holds 10 ownership filings by Dahiyat Bassil I, all Form 4s, filed between Nov 14, 2024 and Jul 2, 2026. Those filings report 17 transactions, from Nov 13, 2024 to Jun 30, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Dahiyat Bassil I's filings is in PALO ALTO, CA.
Recent filings by Dahiyat Bassil I
- Jun 30, 2026: Grant or award of KOD derivative securities (Form 4, code A).
- Mar 6, 2026: Open-market sale of XNCR shares (Form 4, code S).
- Mar 5, 2026: Open-market sale of XNCR shares (Form 4, code S).
- Mar 3, 2026: Open-market sale of XNCR shares (Form 4, code S).
- Mar 2, 2026: Grant or award of XNCR shares (Form 4, code A).
Other insiders filing for Kodiak Sciences Inc. (KOD)
- Yang Taiyin, Director
- BORGESON JOHN A., Chief Financial Officer
- PERLROTH VICTOR, Chairman and CEO
- PROFUSEK ROBERT, Director
- Levy Richard S, Director
- Bancroft Charles A, Director